Schizophrenia Bulletin Advance Access originally published online on July 7, 2006
Schizophrenia Bulletin 2006 32(4):666-678; doi:10.1093/schbul/sbl004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Measuring Changes in Functional Status Among Patients With Schizophrenia: The Link With Cognitive Impairment
2 Center for Health Outcomes Research at UBC, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814
3 Maryland Psychiatric Research Center, Baltimore, MD 21228
4 Capital Health—AHE Neuropsychology, Alberta T5J 2J7, Canada
5 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285
1To whom correspondence should be addressed; tel: 301-664-7263, fax: 301-654-9864, e-mail: louis.matza{at}unitedbiosource.com.
Cognitive impairment associated with schizophrenia (CIAS) includes neuropsychological deficits in attention, working memory, verbal learning, and problem solving. These deficits have been shown to be linked to impairment in functional status (eg, social behavior, work performance, and activities of daily living) among patients with schizophrenia in cross-sectional studies. Less is known about the relationship between cognitive and functional change over time, such as potential functional implications of treatment-related improvement in CIAS. The purpose of this review is to summarize research on the association between change in CIAS and change in functional status, to discuss responsiveness of functional outcomes measures, and to provide recommendations for future research and measure development. Nine longitudinal studies were located on the link between CIAS and functional status, and 8 functional outcomes measures were used across these studies. The 9 studies offer initial support for a link between change in cognitive function and change in functional status. However, inconsistent findings across studies indicate that available research is preliminary, and substantial questions remain unanswered. Shortcomings of functional status measures are noted: most instruments were not developed for the target population, and none have demonstrated responsiveness to cognitive change among schizophrenic patients. It is recommended that new functional outcome measures be developed that are specifically designed to be responsive to change in cognition, with domains previously shown to be related to cognitive ability. When creating new functional outcomes measures for assessment of patients with schizophrenia, responsiveness to change in CIAS should be evaluated as part of the development and validation process.
Keywords: schizophrenia / functional status / cognitive impairment / change / responsiveness
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Robles, A. Zabala, I. Bombin, M. Parellada, D. Moreno, A. Ruiz-Sancho, and C. Arango Cognitive Efficacy of Quetiapine and Olanzapine in Early-Onset First-Episode Psychosis Schizophr Bull, August 25, 2009; (2009) sbp062v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Heinrichs, N. Ammari, A. A. Miles, and S. McDermid Vaz Cognitive Performance and Functional Competence as Predictors of Community Independence in Schizophrenia Schizophr Bull, July 30, 2008; (2008) sbn095v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Stover, S. Marder, and W. Carpenter Progress on NIMH Initiatives (Memorial Theme for Wayne Fenton, MD) Schizophr Bull, September 1, 2007; 33(5): 1084 - 1085. [Full Text] [PDF]
|
|